Clarivate Plc NYSE: CLVT, a leading global provider of transformative intelligence, today released its latest Companies to Watch report, Rediscovering Womens Health , highlighting seven companies driving innovation across reproductive care, chronic disease and mental health. Drawing on proprietary data, expert analysis and insights into therapeutic impact, financing activity and R D momentum, the report showcases why these companies are recognized as high-impact innovators.
Despite representing half the global population, women remain underrepresented in clinical research and healthcare investment, with womens health accounting for just 15 of venture capital and 5 of global healthcare R D funding. Rediscovering Womens Health highlights organizations addressing these gaps through inclusive research, novel therapies and a deeper understanding of female-specific conditions such as early menopause, polycystic ovary syndrome PCOS and endometriosis, factors that influence broader outcomes like cardiovascular disease and dementia. The report also highlights growing momentum in womens health R D.
Anne Lecocq, SVP and GM, R D, Life Sciences Healthcare, Clarivate, said: Womens health is no longer being defined solely by reproductive care its being reframed through a broader lens that recognizes how biological and social factors shape outcomes across every therapeutic area. This shift marks a pivotal moment for the industry, as data-driven innovation and inclusive research begin to translate into more equitable care and better health outcomes for women worldwide. By spotlighting organizations driving this change, the Companies to Watch report underscores how scientific insight and investment can work together to close persistent gaps and advance womens health globally.